Development of a Quantitative Systems Pharmacology (QSP) Model, the Respiratory PhysioPD™ Platform, to Investigate Biological Mechanisms Underlying Bronchoconstriction

被引：0
|
作者：
Friedrich, Christina [1 ]
Weber, Ben [2 ]
Pryor, Meghan [1 ]
Witt, Colleen [1 ]
Borghardt, Jens [2 ]
Disse, Bernd [2 ]
Dallinger, Claudia [3 ]
Gupta, Abhya [2 ]
Singh, Dave
Jung, Birgit [2 ]
Fowler, Andy [2 ]
机构：
[1] Rosa & Co LLC, Biberach, Germany
[2] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-031
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [41] A quantitative systems pharmacology (QSP) model to compare the non-clinical biodistribution and efficacy between recombinant factor IX (rIX) therapies
    Pestel, Sabine
    Chung, Douglas
    Rezvani-Sharif, Alireza
    Muir, Ineke
    Sivamurthy, Krupa
    Brechmann, Markus
    Verhagen, Anne
    Dower, Steve
    van der Graaf, Piet
    Herzog, Eva
    Ghobrial, Oliver
    HAEMOPHILIA, 2022, 28 : 7 - 7
  • [42] A Quantitative Systems Pharmacology Model of Colonic Motility to Aid Drug Discovery and Development
    Zhang Liming
    Raibatak, Das
    Lucia, Wille
    Chen Chunlin
    Jangir, Selimkhanov
    Jill, Wykosky
    Wendy, Winchester
    Cristina, Almansa
    John, Burke
    Fei, Hua
    Majid, Vakilynejad
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S71 - S71
  • [43] Development of a Quantitative Systems Pharmacology Model to Explore Hemostatic Equivalency of Antithrombin Lowering
    Kaddi, Chanchala
    Tao, Mengdi
    Leiser, Randolph
    Salvador, Ane
    Kattula, Sravya
    Bhagunde, Pratik
    Garcia, Viridiana Cano
    Chhabra, Ekta Seth
    Zaph, Susana
    BLOOD, 2022, 140 : 5606 - 5607
  • [44] A Quantitative Systems Pharmacology (QSP) Model for Design and Species-Translation of Bio-Distribution Studies of AAV-Based Gene Therapies
    Narula, Jatin
    Luo, Haobin
    Ko, Glen
    Roy, Mahua
    Pregel, Marko
    Tania, Nessy
    Brodfuehrer, Joanne
    MOLECULAR THERAPY, 2022, 30 (04) : 199 - 200
  • [45] Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder
    Gaweda, Adam E.
    McBride, Devin E.
    Lederer, Eleanor D.
    Brier, Michael E.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (02) : F203 - F211
  • [46] DEVELOPMENT AND VALIDATION OF A QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL OF POTASSIUM-ALDOSTERONE REGULATION.
    Maddah, E.
    Hallow, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S57 - S57
  • [47] Development of a quantitative systems pharmacology model for prediction of mineralcorticoid receptor antagonists-induced hyperkalemia
    Nakada, Tomohisa
    Rengaswamy, Maithreye
    Dasika, Krishnakant
    Kumar, Rukmini
    Saito, Ryuta
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S116 - S116
  • [48] Next-Generation Model-Based Drug Discovery and Development: Quantitative and Systems Pharmacology
    Allerheiligen, S. R. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 135 - 137
  • [49] MULTIPLE MYELOMA QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL: DEVELOPMENT AND USAGE FOR POMALIDOMIDE INFLUENCE EVALUATION.
    Schuck, E.
    Rege, B.
    Ferry, J.
    Hussein, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S86 - S87
  • [50] MULTIPLE MYELOMA QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL: DEVELOPMENT AND USAGE FOR POMALIDOMIDE INFLUENCE EVALUATION.
    Rubina, S.
    Demin, O.
    Demin, O., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S86 - S86
12345